Clinical Trial Update: Safety and Effectiveness of the XEN45 Glaucoma Treatment System in Patients With Angle Closure Glaucoma [Phase 3]

View source ↗

Summary

Phase 3 trial update on the safety and effectiveness of the XEN45 Glaucoma Treatment System in angle-closure glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angle-closure Glaucoma
• Glaucoma

Drugs mentioned

• XEN45 Glaucoma Treatment System

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Angle-Closure | Phase 3 | Status: COMPLETED | Results posted: 2023-05-17